Acer Therapeutics – focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases |
| Altavoz Clinical – enables companies and CROs to build and deploy their own subject data collection solution |
| Anthera Pharmaceuticals – focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases |
| Atacama Therapeutics – focused on advancement of a treatment for hyperhidrosis |
| Beachhead Solutions – offers first-in-class subscription services to enforce encryption and manage security on mobile devices |
| Blueberry Therapeutics – create safe, effective “nanomedicines” with which to treat a number of serious unmet medical needs |
| Calixa Therapeutics – developed novel anti-pseudomonal cephalosporin CXA-101, for cUTI |
| Censa Pharmaceutical – focused on the development of CNSA-001 for orphan diseases |
| Coaxis – developing suture anchors, buttons or pledgets for attaching sutures to bone, cartilage or soft tissue |
| EPM Live – work management platform that revolutionizes the way organizations manage projects and work |
| Kalidex – developed candidate KPI-10, a broad spectrum, next-generation fluoroquinolone |
| Ocuphire Pharma – development and commercialization of drugs to treat important ophthalmic disorders |
| Pacific Pharmaceutical Services – a GMP compliant warehouse offering controlled temperature storage, material dispensing, clinical labeling, logistics support, and CMC advisory services to the global healthcare industry |
| Peninsula Pharmaceuticals – developed doripenem, a broad-spectrum antibiotic and a new member of the carbapenem class of beta-lactam antibiotics |
| Trident Clinical – CRO based in Australia, New Zealand and India |
| Trigemina – targeted Nasal Delivery Technology for pain, migraine headaches, and a variety of complex CNS disorders |
| Veritas Investments – a real estate investment manager that specializes in operating mixed-use multifamily and retail properties in the San Francisco Bay Area |
| Zentalis Pharmaceuticals – discovery and development of small molecule therapeutics targeting fundamental biological pathways of cancer |